Evidence map›Paper›PMID 37370322›Full record

ArticleAntibiotics (Basel, Switzerland)2023

Optimization of Empirical Antimicrobial Therapy in

Brian J Haimerl, Rodrigo Encinas, Julie Ann Justo, Joseph Kohn, P Brandon Bookstaver, Hana Rac Winders, Majdi N Al-Hasan

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Brian J HaimerlDepartment of Medicine, University of South Carolina School of Medicine, Columbia, SC 29209, USA.ORCID 0000-0002-9246-152X
Rodrigo EncinasDepartment of Medicine, University of South Carolina School of Medicine, Columbia, SC 29209, USA.ORCID 0000-0002-4033-9012
Julie Ann JustoDepartment of Clinical Pharmacy and Outcomes Sciences, University of South Carolina College of Pharmacy, Columbia, SC 29208, USA.ORCID 0000-0002-4161-9577
Joseph KohnDepartment of Pharmacy, Prisma Health-Midlands, Columbia, SC 29203, USA.
P Brandon BookstaverDepartment of Clinical Pharmacy and Outcomes Sciences, University of South Carolina College of Pharmacy, Columbia, SC 29208, USA.ORCID 0000-0002-4409-0963
Hana Rac WindersDepartment of Pharmacy, Prisma Health-Midlands, Columbia, SC 29203, USA.ORCID 0000-0002-6203-6522
Majdi N Al-HasanDepartment of Medicine, University of South Carolina School of Medicine, Columbia, SC 29209, USA.ORCID 0000-0001-6501-492X
Prisma Health · USUniversity of South Carolina · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clinical tools for the prediction of antimicrobial resistance have been derived and validated without examination of their implementation in clinical practice. This study examined the impact of utilization of the extended-spectrum beta-lactamase (ESBL) prediction score on the time to initiation of appropriate antimicrobial therapy for bloodstream infection (BSI). The quasi-experimental cohort study included hospitalized adults with BSI due to ceftriaxone-resistant (CRO-R)

Indexed as

antibiotic resistanceantibioticsbacteremiaEscherichia coliGram-negativeKlebsiella speciessepsis

Identifiers

PMID37370322
PMCPMC10295403
OpenAlexW4379472354

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.